Karmelsonix Ltd. (KSX) engages in the research, development and commercialization of medical devices in Australia, Israel and US. The company is recognized as a global leader in developing acoustic respiratory monitoring devices. Its products are based on acoustic signal acquisition technology and advanced analysis capabilities. KSX`s technology consists of signal conditioning hardware, sensors, and an array of signal processing algorithms for automatic detection and quantification of wheezes, cough and respiration. Its technology also finds use in the protection of the inner-body signal against interferences from background noisy acoustic environments, which is found in pulmonary function testing laboratories. Its products include, Wireless PT, ASAM, WHolter, WIM-GER and Personal Wheezometer, and the upcoming product of the company is The Pulmo Track-Wireless. The company operates through three subsidiaries: Karmel Sonix (Israel) Limited, PulmoSonix Pty Ltd and KarmelSonix USA. KSX is headquartered at Armadale in Victoria, Australia.The company reported revenues of (Australian Dollars) AUD 0.43 million during the fiscal year ended June 2009, a decrease of 54.24% from 2008. The operating loss of the company was AUD 6.70 million during the fiscal year 2009, as compared to an operating loss of AUD 11.68 million during 2008. The net loss of the company was AUD 6.70 million during the fiscal year 2009, as compared to a net loss of AUD 11.68 million during 2008.